Faculty Information - WATANABE Daisuke

（Last updated : 2026-07-18 06:37:52）

WATANABE Daisuke
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Endocrinology and Hypertension

Position Assistant Professor

■ Published papers

1.	Original article	Clinical implications of aldosterone responsiveness to adrenocorticotropic hormone stimulation in two major subtypes of primary aldosteronism. 2026/12
2.	Original article	Association between adipose (pro)renin receptor expression and growth hormone deficiency in patients with non-functioning hypothalamic-pituitary masses 2026/07
3.	Case report	Drug-Induced Liver Injury Due to Potassium Iodide During Thyroid Storm 2026/04/21
4.	Case report	Romosozumab Treatment after Parathyroidectomy for Primary Hyperparathyroidism-complicated Osteoporosis: A Two-Case Report 2026/04
5.	Original article	Clinical and radiological features of Rathke's cleft cysts with inflammatory change: Multivariable analysis of 262 surgically treated cases. 2026/03
6.	Case report	Primary Adrenal Insufficiency Due to Recurrent Unilateral Adrenal Infarction in a Patient With Myelodysplastic Syndrome with Isolated del(5q) 2025/09/11
7.	Case report	A Rare Coexistence of Thyrotropin-Secreting Pituitary Adenoma and Graves Disease. 2025/09
8.	Original article	Reduced high-sensitivity C-reactive protein levels following weekly somapacitan in adults with growth hormone deficiency: a prospective pilot study 2025/07/29
9.	Case report	Subacute thyroiditis during anti-programmed cell death protein 1 antibody therapy: A case report 2025/05
10.	Original article	Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism 2023/12/12
11.	Original article	Effect of GH Deficiency Caused by Nonfunctioning Pituitary Masses on Serum C-reactive Protein Levels. 2023/11
12.	Original article	Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus. 2023/10
13.	Original article	Cardiovascular risk assessments in patients with cortisol-producing adenoma: impact of clinical features and genetic characteristics 2023/09/11
14.	Original article	Hyperuricemia and the Severity of Coronavirus Disease 2019 in Japan: A Retrospective Cohort Study - An Inseparable Relation with Hypertension and Chronic Kidney Disease 2023
15.	Original article	Comparison of the usefulness of the cardio-ankle vascular index and augmentation index as an index of arteriosclerosis in patients with essential hypertension. 2021/12
16.	Original article	Immunohistochemistry for (pro)renin receptor in humans 2021/07/28
17.	Original article	Transient Leukopenia After Radioactive Iodine Treatment in Patients With Graves’ Disease: A Retrospective Cohort Study 2021/03/06
18.	Original article	Comparison of Shortened with Standard Saline Infusion Test for Primary Aldosteronism Diagnostics 2020/05/08
19.	Original article	Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism 2020/04/30
20.	Original article	Adrenal n(pro)renin receptor expression and serum soluble (pro)renin receptor concentration in primary aldosteronism 2020
21.	Case report	Primary aldosteronism in Klinefelter’s syndrome: two cases 2019/12
22.	Original article	Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism. 2019/12
23.	Case report	ACTH-Dependent Cyclic Cushing Syndrome Triggered by Glucocorticoid Excess Through a Positive-Feedback Mechanism. 2019/05
24.	Original article	Fatal Fournier's gangrene caused by Clostridium ramosum in a patient with central diabetes insipidus and insulin-dependent diabetes mellitus: a case report. 2018/08
25.	Original article	Greater reductions in plasma aldosterone with aliskiren in hypertensive patients with higher soluble (Pro)renin receptor level. 2018/06
26.	Original article	Complete remission of hypertension in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation. 2018/05
27.	Original article	Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease. 2018
28.	Original article	Body mass index and contralateral ratio predict outcome following unilateral adrenalectomy in primary aldosteronism. 2017/12
29.	Original article	The relationships between the differences in central blood pressure and brachial blood pressure and other factors in patients with essential hypertension 2017
30.	Original article	Evaluation of insulin sensitivity and secretion in primary aldosteronism. 2016/09
31.	Case report	Osteomalacia, severe thoracic deformities and respiratory failure in a young woman with anorexia nervosa. 2015/04
32.	Review article	Serum soluble (pro)renin receptor levels in patients with essential hypertension. 2014
33.	Original article	Prediction of gestational diabetes mellitus by soluble (pro)renin receptor during the first trimester. 2013/06
34.	Original article	Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders 2009
Display 5 items
Display all(34)

■ Academic conference presentation

1.	A Case of Severe Heart Failure Due to Primary Aldosteronism with Improved Cardiac Function Following Adrenalectomy （ポスター掲示，一般） 2026/10/18
2.	Two Cases of Renovascular Hypertension Diagnosed after Stillbirth and Successfully Treated with Percutaneous Transluminal Renal Angioplasty （ポスター掲示，一般） 2026/05
3.	The Impact of Inpatient Educational Interventions on Patient Understanding and Behavioral Change in Hypertension Management （ポスター掲示，一般） 2025/10/19
4.	Impact of surgical therapy and mineralocorticoid receptor antagonist therapy on left ventricular hypertrophy in patients with primary aldosteronism （口頭，一般） 2025/10/18
5.	Acromegaly and Polycystic Kidney Disease in a Young Patient with Hypertension （口頭，一般） 2025/10/17
6.	Thyrotropin Level Predicts Postoperative Hypothyroidism in Patients with Nonfunctioning Pituitary Masses （ポスター掲示，一般） 2025/07
7.	Primary adrenal insufficiency due to recurrent episodes of unilateral adrenal infarction （ポスター掲示，一般） 2025/05
8.	Weekly Somapacitan Reduces Serum C-reactive Protein Levels in Adult Patients with Growth Hormone Deficiency （ポスター掲示，一般） 2024/06/03
9.	Increased prevalence of uterine myoma in patients with idiopathic hyperaldosteronism （ポスター掲示，一般） 2024/06/01
10.	A Case of Acromegaly Due to GH-secreting Tumor Mimicking ACTH Co-secretion （ポスター掲示，一般） 2024/05
11.	Comparison of antihypertensive effects between eplerenone and esaxerenone, mineralocorticoid receptor antagonists, in patients with primary aldosteronism （ポスター掲示，一般） 2024/05
12.	Romosozumab Therapy After Parathyroidectomy for Osteoporosis Caused by Primary Hyperparathyroidism: Two Case Reports （ポスター掲示，一般） 2024/05
13.	A decrease in serum CRP levels after somapacitan therapy for adult growth hormone deficiency （口頭，一般） 2024/02/16
14.	Growth hormone secretion and serum high-sensitivity C-reactive protein levels in adult patients with non-functioning pituitary tumors （ポスター掲示，一般） 2023/06/17
15.	A negative association between growth hormone secretion and inflammation in adult patients with non-functioning pituitary mass （ポスター掲示，一般） 2023/05/15
16.	Renoprotective Effect of Aliskiren Monotherapy in Hypertensive Patients with Obesity and Type 2 Diabetes Mellitus （ポスター掲示，一般） 2022/10/15
17.	Association between cardiac (pro)renin receptor expression and myocardial hypertrophy in human （ポスター掲示，一般） 2021/04
18.	Primary Aldosteronism in Klinefelter's Syndrome: Two Cases Report （ポスター掲示，一般） 2018/09/22
19.	Primary Hyperparathyroidism in a Patient with Primary Aldosteronism （ポスター掲示，一般） 2018/09/22
20.	Renoprotective Effect of Direct Renin Inhibitor Monotherapy in Hypertensive Patients with Type 2 Diabetes or Obesity （口頭，一般） 2018/09/14
21.	Serum soluble (pro)renin receptor concentration is correlated with organ dysfunctions in patients with primary aldosteronism （ポスター掲示，一般） 2018/09
22.	An old patient with acromegaly treated with consideration of past history and preventing frailty （口頭，一般） 2018/02/09
23.	(Pro)renin receptor immunohistochemistry in human organs 2016/09
24.	A novel biomarker urinary soluble (pro)renin receptor excretion is associated with urineph 2016/09
25.	Evaluation of Insulin Sensitivity and Secretion in Primary Aldosteronism. (Pro)renin receptor immunohistochemistry in human organs. 2016/09
26.	Relationships between serum soluble (pro)renin receptor levels and endocrine or metabolic factors in patients with essential hypertension. 2015/09
27.	Serum soluble (pro)renin receptor levels in patients undergoing hemodialysis 2015/09
28.	A case of hemodialysis patient with primary aldosteronism which was difficult to differentiate from pheochromocytoma 2015/05
29.	A Circulating Soluble (Pro)Renin Receptor Level and Its Changes with Growth Hormone replacement in Patients with Growth Hormone Deficiency 2014/06/21
30.	Associations between renal function and indices of renin-angiotensin system in patients with essential hypertension 2014/05
31.	Effects of the direct renin inhibitor on renin-angiotensin system in hypertensive patients with chronic kidney disease 2014/05
32.	Serum soluble (Pro)renin receptor levels in maintenance hemodialysis patients 2014/05
33.	Clinical implications of the difference in central blood pressure and brachial blood pressure in patients with essential hypertension 2014/04
34.	CVD therapy for unresectable pheochromocytoma （ポスター掲示，一般） 2013/08
35.	Periodic ectopic Cushing's syndrome potentially evoked by glucocorticoid excess （ポスター掲示，一般） 2013/06/16
Display 5 items
Display all(35)

■ Education

2005/04～2009/03

〔Doctoral course〕〔Doctorial Course〕, Tokyo Women's Medical University, Completed,